Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Definitive Healthcare (DH) Cash from Restructuring (2024 - 2025)

Definitive Healthcare (DH) has disclosed Cash from Restructuring for 2 consecutive years, with $243000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Restructuring rose 26.56% year-over-year to $243000.0, compared with a TTM value of $595000.0 through Dec 2025, down 51.98%, and an annual FY2025 reading of $595000.0, down 51.98% over the prior year.
  • Cash from Restructuring was $243000.0 for Q4 2025 at Definitive Healthcare, up from $160000.0 in the prior quarter.
  • Across five years, Cash from Restructuring topped out at $1.0 million in Q2 2024 and bottomed at $160000.0 in Q3 2025.